PAVmed (PAVM) EPS (Diluted) Growth (1y) (2017 - 2025)
PAVmed (PAVM) EPS (Diluted) Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.71% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.88% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 98.71% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 95.96% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -29.80% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 114.19% |
| 10 | PAVmed | 11.39 Mn | 9.86 Mn | -4,000.00 | -548.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -548.04% |
| Jun 30, 2025 | 38.25% |
| Mar 31, 2025 | 112.86% |
| Dec 31, 2024 | 100.94% |
| Jun 30, 2024 | 43.26% |
| Mar 31, 2024 | 5.78% |
| Dec 31, 2023 | 36.39% |
| Sep 30, 2023 | 45.68% |
| Jun 30, 2023 | 52.43% |
| Mar 31, 2023 | 85.80% |
| Dec 31, 2022 | 82.70% |
| Sep 30, 2022 | 69.20% |
| Jun 30, 2022 | 66.93% |
| Mar 31, 2022 | -78.20% |
| Dec 31, 2021 | -96.15% |
| Sep 30, 2021 | -121.23% |
| Jun 30, 2021 | -104.37% |
| Mar 31, 2021 | 34.64% |
| Dec 31, 2020 | -39.58% |
| Sep 30, 2020 | -76.24% |